ProfileGDS4718 / 1555630_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 56% 62% 96% 56% 63% 51% 59% 60% 65% 60% 59% 69% 56% 60% 58% 68% 67% 68% 57% 78% 66% 67% 64% 64% 65% 61% 62% 59% 58% 50% 53% 77% 67% 52% 75% 69% 55% 69% 61% 97% 60% 52% 92% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.888256
GSM549102patient 115, normal, homogenized [OPG study]6.2769862
GSM549104patient 119, normal, homogenized [OPG study]10.631796
GSM549108patient 138, normal, homogenized [OPG study]5.9239256
GSM549119patient 077, normal, homogenized [OPG study]6.3446463
GSM549133patient 032, cancer, homogenized [OPG study]5.5280151
GSM549139patient 042, cancer, homogenized [OPG study]6.0278959
GSM549099patient 107, normal, homogenized [OPG study]6.1459360
GSM549109patient 139, normal, homogenized [OPG study]6.4481465
GSM549110patient 046, normal, homogenized [OPG study]6.1397360
GSM549114patient 063, normal, homogenized [OPG study]6.0144459
GSM549122patient 082, normal, homogenized [OPG study]6.8470769
GSM549134patient 033, cancer, homogenized [OPG study]5.8558956
GSM549136patient 036, cancer, homogenized [OPG study]6.1254460
GSM549140patient 044, cancer, homogenized [OPG study]5.9881558
GSM549111patient 047, normal, homogenized [OPG study]6.7439968
GSM549113patient 057, normal, homogenized [OPG study]6.6223967
GSM549132patient 031, cancer, homogenized [OPG study]6.7497168
GSM549137patient 038, cancer, homogenized [OPG study]5.9503257
GSM549142patient 047, cancer, homogenized [OPG study]7.4702178
GSM549100patient 110, normal, homogenized [OPG study]6.5439266
GSM549107patient 135, normal, homogenized [OPG study]6.6207367
GSM549115patient 068, normal, homogenized [OPG study]6.3691164
GSM549116patient 072, normal, homogenized [OPG study]6.4511764
GSM549120patient 078, normal, homogenized [OPG study]6.4457165
GSM549131patient 030, cancer, homogenized [OPG study]6.2112161
GSM549118patient 074, normal, homogenized [OPG study]6.2958562
GSM549129patient 027, cancer, homogenized [OPG study]6.0555259
GSM549123patient 088, normal, homogenized [OPG study]5.9998658
GSM549124patient 006, cancer, homogenized [OPG study]5.5484150
GSM549126patient 015, cancer, homogenized [OPG study]5.6463753
GSM549128patient 025, cancer, homogenized [OPG study]7.6458777
GSM549103patient 117, normal, homogenized [OPG study]6.5877567
GSM549117patient 073, normal, homogenized [OPG study]5.5681452
GSM549138patient 041, cancer, homogenized [OPG study]7.4057975
GSM549141patient 045, cancer, homogenized [OPG study]6.8522369
GSM549130patient 028, cancer, homogenized [OPG study]5.8321155
GSM549101patient 111, normal, homogenized [OPG study]6.8216869
GSM549105patient 128, normal, homogenized [OPG study]6.2245461
GSM549106patient 134, normal, homogenized [OPG study]10.984697
GSM549112patient 048, normal, homogenized [OPG study]6.1339260
GSM549125patient 011, cancer, homogenized [OPG study]5.6429652
GSM549127patient 024, cancer, homogenized [OPG study]9.3776992
GSM549135patient 035, cancer, homogenized [OPG study]6.2889962